81600-93-3

Basic information

• Product Name: allyl 4,6-di-O-benzylidene-α-D-mannopyranoside
• Synonyms: allyl 4,6-di-O-benzylidene-α-D-mannopyranoside
• CAS NO: 81600-93-3
• Molecular Weight: 308.331
• Mol File: 81600-93-3.mol
• Article Data: 18

Chemical Properties

• CAS DataBase Reference: allyl 4,6-di-O-benzylidene-α-D-mannopyranoside(CAS DataBase Reference)
• NIST Chemistry Reference: allyl 4,6-di-O-benzylidene-α-D-mannopyranoside(81600-93-3)
• EPA Substance Registry System: allyl 4,6-di-O-benzylidene-α-D-mannopyranoside(81600-93-3)

Safety Data

• Hazardous Substances Data: 81600-93-3(Hazardous Substances Data)

Usage

Description

Allyl 4,6-di-O-benzylidene-α-D-mannopyranoside is a chemical compound derived from the sugar mannose, commonly used in organic synthesis as a protecting group for the hydroxyl group of mannose. The allyl group serves as a temporary protective group that can be easily removed under mild conditions, allowing for selective modification of the mannose molecule. The benzylidene groups also provide protection for the sugar, preventing unwanted reactions during synthetic processes.

Uses

Used in Carbohydrate Chemistry:
Allyl 4,6-di-O-benzylidene-α-D-mannopyranoside is used as a protecting group for the hydroxyl group of mannose in carbohydrate chemistry, enabling selective modification of the mannose molecule.
Used in Glycosylation Reactions:
Allyl 4,6-di-O-benzylidene-α-D-mannopyranoside is used as a protecting group in glycosylation reactions to create complex sugar structures with precise control over functionality.

Upstream product

• 2595-07-5 allyl β-D-glucopyranoside 
• 1125-88-8 benzaldehyde dimethyl acetal 
• 100-52-7 benzaldehyde 
• 48149-74-2 allyl D-glucopyranoside 
• 572-09-8 2,3,4,6-tetra-O-acetyl-α-D-glucopyranosyl bromide 
• 41308-76-3 allyl α-D-mannopyranoside 
• 3458-28-4 D-Mannose 
• 7296-15-3 alpha-D-mannopyranoside 
• 492-61-5 β-D-glucose 
• 10343-15-4 Acetic acid (2R,3R,4S,5R,6R)-3,5-diacetoxy-2-acetoxymethyl-6-allyloxy-tetrahydro-pyran-4-yl ester 
• 604-69-3 β-D-glucose pentaacetate 
• 2280-44-6 D-Glucose 
• 10343-15-4 allyl 2,3,4,6-tetra-O-acetyl-D-galactopyranoside 
• 25878-60-8 D-galactose pentaacetate 

Downstream Products

• 145773-08-6 allyl 2,3-di-O-benzyl-4,6-O-benzylidene-β-D-glucopyranoside 
• 760178-19-6 1-O-allyl-2,3-di-O-benzyl-6-O-tosyl-β-D-glucose 
• 760178-20-9 1-O-allyl-2,3-di-O-benzyl-4-O-(carbobenzoxy-β-alanyl)-6-O-tosyl-β-D-glucopyranoside 
• 760178-21-0 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-6-allyloxy-4,5-bis-benzyloxy-tetrahydro-pyran-3-yl ester 
• 760178-22-1 3-Benzyloxycarbonylamino-propionic acid (2S,3S,4S,5R,6R)-2-acetylsulfanylmethyl-4,5-bis-benzyloxy-6-(2,3-dihydroxy-propoxy)-tetrahydro-pyran-3-yl ester 
• 1234307-27-7 C₅₄H₇₇NO₁₂S 
• 760178-23-2 Octadecanoic acid 2-[(2R,3R,4S,5S,6S)-6-acetylsulfanylmethyl-3,4-bis-benzyloxy-5-(3-benzyloxycarbonylamino-propionyloxy)-tetrahydro-pyran-2-yloxy]-1-octadecanoyloxymethyl-ethyl ester 
• 99541-24-9 O-(2,3-di-O-benzyl-β-D-glucopyranosyl)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 99541-26-1 O-(methyl 2,3-di-O-benzyl-β-D-glucopyranosyluronate)-(1->4)-3-O-acetyl-1,6-anhydro-2-azido-2-deoxy-β-D-glucopyranose 
• 119237-90-0 allyl 3-O-benzyl-4,6-O-benzylidene-α-D-mannopyranoside 
• 612057-03-1 allyl 2,3,4,6-tetra-O-benzoyl-α-D-mannopyranosyl-(1->3)-4,6-O-benzylidene-α-D-mannopyranoside 

Relevant articles and documents

A Synthetic Carbohydrate-Protein Conjugate Vaccine Candidate against Klebsiella pneumoniae Serotype K2

Klebsiella pneumoniae causes pneumonia and liver abscesses in humans worldwide and contains virulence factor capsular polysaccharides and lipopolysaccharides linked to the cell wall. Although capsular polysaccharides are good antigens for vaccine producti

2,4,6-Trichloro-1,3,5-triazine (TCT) mediated one-pot sequential functionalisation of glycosides for the generation of orthogonally protected monosaccharide building blocks

Orthogonally protected monosaccharide building blocks have been prepared using TCT in a one-pot multicomponent transformation. The process involves successive steps of arylidene acetalation, esterification and regioselective reductive acetal cleavage. High regioselectivity, scope for using a broad range of substrates, functional group tolerance, mild reaction conditions, easy handling process and wide application range are a few advantages of the current process.

COMPOUND RETAINED IN TUMOR

A novel compound which specifically resides in a tumor, a method for allowing it to reside in a tumor, and a method for detecting, diagnosing, and treating tumor with use thereof are provided. The present invention relates to a compound represented by chemical formula (I) wherein R is an anionic group binding to hydrogen, R1 is OH, OCOH, OCO(CH2)hCH3, or an acting group, h being an integer of 0 or more, R2 is H, OH, OCOH, OCO(CH2)iCH3, or an acting group, i being an integer of 0 or more, R3 is OH, SO3H, or an acting group, R4 is OH, SO3H, or an acting group, and R5 is OH, SO3H, or an acting group, at least one of R1, R2, R3, R4, and R5 containing an acting group, or pharmaceutically acceptable salts thereof.